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Abstract 
Alarmins are a heterogeneous group of endogenous molecules that signal cellular 
damage when sensed extracellularly. Heme is an endogenous molecule that acts as a 
prosthetic group of hemoproteins, such as hemoglobin and myoglobin. When released 
from damaged red blood cells or muscle cells, oxidized hemoglobin and myoglobin 
release their prosthetic heme groups, respectively. This generates labile heme, which is 
sensed by pattern recognition receptors (PRR) expressed by innate immune cells and 
possibly regulatory T cells (TREG). The ensuing adaptive response, which alerts for the 
occurrence of red blood cell or muscle cell damage, regulates the pathologic outcome of 




This opinion article builds up on several assumptions. First, that all living organisms can 
sense events that alert for a possible disruption of homeostasis [1]. Second, that such 
sensors trigger adaptive responses that contribute to maintain or restore homeostasis 
[2,3]. Third, that host/microbe interactions often lead to disruption of homeostasis. 
Fourth, that sensing microorganisms alert for a possible disruption of homeostasis. 
Based on these general principles pattern recognition receptors (PRRs) where proposed 
to act as bona fide homeostatic sensors [1]. 
Engagement of PRR by pathogenic microorganisms is essential to elicit adaptive 
immune responses conferring resistance to infections [4,5]. In addition, PRR also play a 
pivotal role in maintaining steady state interactions with commensal microorganisms, as 
*Manuscript
Click here to view linked References
 2 
illustrated originally for host/microbiota interactions [6]. Moreover, PRR can sense 
endogenous molecules released from damaged cells [7], presumably reporting on 
cellular damage and on possible disruption of homeostasis. The endogenous molecules 
recognized by PRR were originally designated as danger associated molecular patters, 
based on the assumption that these are sensed when released from damaged cells 
[8,9]. The term alarmin is also used to refer to any endogenous molecule that signals 
cellular damage [10]. We shall argue herein that labile heme is a prototypical alarmin. 
 
Labile Heme 
Heme is an evolutionarily conserved molecular structure composed of a tetrapyrrole ring 
surrounding a single iron (Fe) atom (Figure 1). Heme acts essentially as a prosthetic 
group in a number of hemoproteins. These include hemoglobin (Hb) and myoglobin 
(Mb), which contain the largest pool of bioavailable heme in mammals [11]. When 
damaged, red blood cells and muscle cells release Hb and Mb, respectively. 
Extracellular Hb and Mb are readily oxidized, via a process catalyzed by the transition of 
iron-heme from ferrous (Fe++) to ferric (Fe+++) state. This gives rise to methemoglobin 
[12-14] and metmyoglobin [15], respectively, which can release their prosthetic heme 
groups and generate labile heme, that is, redox active heme that is loosely bound to 
proteins or molecules, other than hemoproteins. 
Under homeostatic conditions, extracellular Hb and labile heme are scavenged in 
plasma by haptoglobin and hemopexin, respectively [16,17]. Whether extracellular Mb is 
also scavenged in plasma is, to the best of our knowledge, not established. The resulting 
haptoglobin/Hb and hemopexin/heme complexes are captured by 
monocyte/macrophages (Mø) via the CD163 and CD91 receptors, respectively. This is 
associated with the induction of heme oxygenase-1 (HO-1) expression, a heme-
catabolizing enzyme that generates carbon monoxide (CO), labile iron and biliverdin 
(reviewed in [11]). The end-products of heme catabolism can modulate Mø polarization, 
as demonstrated originally for CO [18]. Of note, when generated by Mø CO acts as a 
“microbial metabolic sensor” that fine-tunes Mø responses to live versus dead bacteria 
[19]. 
When the “scavenging capacity” of haptoglobin and hemopexin is exhausted, labile 
heme accumulates in plasma, where it becomes loosely bound to other plasma 
molecules that fail to restrain its redox activity. As such, labile heme becomes pro-
 3 
oxidant and presumably therefore pathogenic. This pathogenic effect is perhaps best 
illustrated in the context of hemolytic conditions such as sickle cell disease, caused by 
mutations in the  chain of Hb [20-22], malaria caused by Plasmodium infection [14,23-
25] or severe sepsis caused by systemic infections [26].  
 
Sensing labile heme 
The finding that when exposed in vitro to labile heme Mø secrete tumor necrosis factor 
(TNF) via a mechanism dependent on the expression of TLR4 and its adaptor signaling 
molecule MyD88, revealed that labile heme can be sensed by PRR [27]. More recently 
labile heme was shown to induce, again via a TLR4-dependent mechanism, the 
expression of molecules associated with endothelial cell activation, an effect that 
presumably contributes to the pathogenesis of sickle cell disease [20,22]. Labile heme 
acts irrespectively of the toll-Interleukin receptor (TIR) domain-containing adaptor-
inducing interferon- (IFN-)(TRIF) and fails to induce the expression of co-stimulatory 
molecules that support dendritic cell immunogenicity. This suggests that in contrast to 
other alarmins, labile heme has little or no “adjuvant” activity.  
Murine Mø also secrete interleukin 1 IL-1 when exposed in vitro to labile heme 
[28]. This occurs via a mechanism dependent on the expression of the NOD-like 
receptor 3 (NLRP3) inflammasome, a cytosolic complex that includes the adaptor protein 
apoptosis-associated speck-like protein (ASC) and caspase-1, which processes pro-IL-
1β into IL-1β [28]. Activation of the NLRP3 inflammasome in response to heme occurs 
through a mechanism dependent on the phosphorylation of the spleen tyrosine kinase 
(Syk) as well as the production of reactive oxygen species (ROS) and cellular K+ efflux, 
while acting independently of lysozomal damage or cathepsin activity [28]. These 
findings add labile heme to a number of structurally unrelated endogenous molecules 
sensed by the NLRP3 inflammasome. The observation that mice in which the Nlrp3, 
Asc, caspase 1/11 or Il1r alleles are deleted are more resilient to hemolysis [28], 
suggests that unfettered NLRP3 inflammasome activation and IL-1 secretion in 





Labile heme is an Alarmin 
Given the extraordinarily high intracellular heme content of red blood cells and muscle 
cells, as compared to any other cell type, sensing extracellular labile heme probably 
signals red blood cell and/or muscle cell damage, associated with hemolysis or 
rhabdomyolysis, respectively (Figure 2). In keeping with this notion, labile heme triggers 
cell autonomous and systemic adaptive responses that mitigate the pathogenic 
outcomes of hemolysis [25,29] and rhabdomyolysis [30]. This protective effect is 
mediated via a mechanism involving the expression of HO-1 [13,14]. A similar adaptive 
response, involving the expression of HO-1, contributes to the protective effect of sickle 
cell Hb against malaria [24,31]. Whether this involves heme sensing by PRR is likely, but 
remains to be established. 
Alarmins can promote tissue damage repair, as illustrated in the context of muscle 
[32], intestinal [33] and lung [34] injury. The mechanisms via which this occurs are 
unclear but have been shown to involve the recruitment of tissue resident TREG that can 
sense alarmins. Upon migration, tissue resident TREG preserve the functional integrity of 
damaged tissues [32-34] via a mechanism involving the expression of molecules that act 
directly on parenchyma cells [34] and/or that polarize tissue-resident Mø towards tissue 
repair [32]. Whether labile heme, when released from damaged cells, acts in a similar 
manner is likely, but this has not been reported. In support of this notion, TREG express 
TLR4 [35] and as such may sense labile heme. Moreover, induction of HO-1 in TREG has 
been associated with enhanced TREG function, which may contribute to tissue repair in a 
range of immune mediated inflammatory conditions where HO-1 is protective [13,36,37].  
 
Labile heme as an amplifier of inflammation 
Systemic infections are often associated with varying levels of hemolysis and in some 
cases with rhabdomyolysis as well. The extracellular Hb generated through hemolysis 
exerts anti-microbial effects, via the peroxidase activity of its prosthetic heme b groups, 
which uses hydrogen peroxide (H2O2) to oxidize molecules in microbes [38,39]. 
Moreover, binding of extracellular Hb to bacterial lipopolysaccharide (LPS) [40], alters 
the tertiary structure of Hb [39,41], enhancing its peroxidase and hence microbicidal 
activity [38,39]. Extracellular Hb enhances the pro-inflammatory activity of LPS [41] and 
when overtly oxidized can form large aggregates that act per se as a pro-inflammatory 
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agonist in endothelial cells [42]. This suggests that extracellular Hb acts as a soluble 
PRR and a cytotoxic molecule promoting resistance to systemic infections [40]. 
When released from oxidized Hb and probably from other hemoproteins as well, labile 
heme can exert cytotoxic effects on pathogens, as illustrated for bacteria [43] and 
protozoan parasites [44]. Labile heme also synergizes with LPS to induce cytokine 
production in Mø [45], suggesting that under suboptimal microbial sensing via PRR [45], 
labile heme provides an amplification system that boosts inflammation. Presumably this 
enhances resistance to infection, a feature shared with other alarmins.  
 
Labile heme as a cytotoxic agonist 
Labile heme is not only a cytotoxic to pathogens but also to host cells [44,46,47]. The 
very same structural features that render heme b a versatile redox active molecule when 
contained in the heme pockets of hemoproteins, drive its pathologic effects when 
released from those hemoproteins. The general principle being that the amphipathic 
nature of the tetrapyrrole ring of heme favors its interaction with nonpolar molecules 
such as phospholipids in cellular membranes. If not countered promptly, via heme 
cellular export [48] or catabolism [13,14], labile heme catalyzes lipid peroxidation, 
leading to programmed cell death [12-14,23,26,47]. Presumably this cytotoxic effect 
contributes critically to tissue damage associated with the pathogenesis of sickle cell 
disease [20-22], malaria [14,23-25] and severe sepsis [26].  
Labile heme interacts synergistically with pro-inflammatory cytokines such as TNF 
[23] as well as other agonists such as Fas, ROS and reactive nitrogen species (RNS) 
[13,26] to induce programmed cell death in a variety of parenchyma cells 
[13,14,23,26,47,49,50]. Briefly, labile heme sensitizes parenchyma cells to undergo 
TNF-mediated programmed cell death via a mechanism that involves the iron contained 
in its tetrapyrrole ring, which reacts with hydrogen peroxide (H2O2) and catalyzes, via the 
Fenton chemistry, the production of hydroxyl radicals (OH.) [13,51]. Sustained ROS 
production overrides the cytoprotective program triggered via activation of the nuclear 
factor kappa B (NF-B) family of transcription factors [52] and sustains the activation of 
the c-Jun N-terminal Kinase (JNK) leading to programmed cell death [49][53,54]. 
Presumably, this occurs via inhibition of redox-sensitive phosphatases that control JNK 
activation in response to TNF [55,56]. In keeping with this notion, antioxidants such as 
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the glutathione precursor N-acetyl cysteine suppress heme-driven JNK activation and 
the cytotoxic effect of labile heme and TNF [13,14,23,26,49,57]. Moreover, intracellular 
sequestration of labile iron by ferritin acts as an endogenous anti-oxidant that prevents 
sustained JNK activation and programmed cell death in response to heme and TNF [52]. 
This suggests that in parenchyma cells the pro-oxidant effect of labile heme is mediated, 
at least in part by iron, when released from the protoporphyrin ring of heme [13,23]. 
The effector mechanisms underlying the cytotoxic effect of labile heme in 
parenchyma are likely cell-type specific. Based on morphological and biochemical 
characteristics, including caspase-3 activation, membrane blebbing, nuclear 
shrinking/fragmentation, chromatin condensation and formation of apoptotic bodies, 
labile heme appears to sensitize hepatocytes to undergo apoptosis in response to TNF 
[23]. 
Mø also undergo programmed cell death when exposed to labile heme [58]. However, 
labile heme induces Mø to undergo necroptosis, rather than apoptosis. This occurs 
through a mechanism involving TLR4-driven NF-B activation, the production of TNF 
and TNF receptor 1 (TNFR1) signaling. Sustained ROS production drives JNK and 
receptor-interacting serine/threonine-protein kinase (RIPK) 1 and RIPK3 activation, 
leading to necroptosis [58]. The pro-oxidant effect of labile heme in Mø occurs 
independently of TLR4 [27] but involves the expression of NADPH oxidase-2 
(NOX2)/gp91phox [59-61] and the mitochondrial electron transport chain [28,62]. Whether 
ROS production also involves a receptor-mediated process that senses labile heme is 
not clear. A similar signal transduction pathway, leading to programmed cell death, 
applies to microglia [63] and to astrocytes [64]. 
The mechanism via which labile heme triggers programmed cell death in Mø 
contrasts to some extent with the one operating in parenchyma cells, which fail to 
produce TNF in response to labile heme. As such labile heme per se does not trigger 
programmed cell death in parenchyma cells. Heme becomes cytotoxic to parenchyma 
cells, only in the presence of exogenous TNF, ROS or RNS produced by bystander cells 




Labile heme is a prototypical alarmin. In contrast to other alarmins however, labile heme 
is endowed with cytotoxicity, potentially amplifying the release of other alarmins from 
damaged cells. Presumably this explains the broad protective effects exerted by the 
adaptive response triggered in response to this alarmin, which converges at the level of 
heme catabolism by HO-1 and act in a protective manner against a variety of immune 
mediated inflammatory diseases. 
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BOX1: Heme as a TLR4 agonist:  
 
Figure legends 
Figure 1: Specific alterations in the vinyl and methyl groups of the tetrapyrrole ring of 
heme define heme a (C49H56O6N4Fe), b (C34H32O4N4Fe) and c (C34H36O4N4S2Fe). Heme 
a associates, via hydrogen bonds formed by the formyl and hydroxyfarnesylethyl groups 
of the tetrapyrrole ring, with arginines and serines in hemoproteins such as cytochrome c 
oxidase. Heme c is less abundant and binds covalently, through the tetrapyrrole vinyl 
groups, to cysteines in hemoproteins such as cytochrome c. Heme b, the most abundant 
form of heme, associates via van der Waals contacts and salt-bridges in the propionate 
group of the tetrapyrrole ring, to hydrophobic amino acids in hemoproteins, such as 
hemoglobin (Hb) and myoglobin (Mb). 
 
Figure 2: Labile heme acts as a bona fide inflammatory agonist, inducing the activation 
and migration of polymorphonuclear (PMN) cells [59,60,66] as well as the activation of 
Mø [59,61,62,67-69] and endothelial cells [20]. In some cases this is mediated via a 
mechanism involving heme sensing by PRR [20,27,28] as well as G coupled proteins 
When assigning an endogenous molecule as a putative TLR4-ligand one should 
consider the possibility that this molecule may be contaminated by LPS (i.e. 
endotoxin), a promiscuous TLR4-ligand present in many commercially available 
reagents. In the case of labile heme this possibility was excluded by a series of 
independent observations; i) LPS, e.g. lipid A, antagonists fail to inhibit the pro-
inflammatory activity of labile heme and antibodies that block the binding of LPS to 
TLR4 and/or to MD-2 fail to inhibit the pro-inflammatory activity of labile heme [27]; ii) 
Protoporphyrin IX, a tetrapyrrole ring identical to heme but lacking the iron molecule, 
acts as competitive inhibitor of labile heme while not interfering with the activity of LPS 
[27], iii) Serum blocks the pro-inflammatory activity of labile-heme while supporting that 
of LPS [27]; iv) The pro-inflammatory activity of labile heme acts irrespectively of the 
Toll-Interleukin receptor (TIR) domain-containing adaptor-inducing interferon- (IFN) 
(TRIF) or MD-2 [27,58]. This argues that labile heme is an endogenous TLR4 ligand 
that binds to TLR4 in a distinct manner from LPS [65]. 
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(GCP) in PMN cells [59]. This argues that extracellular labile heme acts as an alarmin, 
that is, an endogenous molecule that when sensed in the extracellular space signals 
cellular damage [10]. 
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